BlackRock Institutional Trust’s Kindred Biosciences, Inc. KIN Stock Holding History

BlackRock Institutional Trust’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$248K	Sell	58,390 -476	-0.8%	-$2.3K	﹤0.01%	3565
2016 Q3	$294K	Sell	58,866 -3,316	-5%	-$14K	﹤0.01%	3576
2016 Q2	$220K	Sell	62,182 -6,103	-9%	-$22.4K	﹤0.01%	3622
2016 Q1	$236K	Buy	68,285 +45,930	+205%	+$162K	﹤0.01%	3597
2015 Q4	$76K	Buy	+22,355	New	+$104K	﹤0.01%	3778
2015 Q2	–	Sell	-87,354	Closed	-$624K	–	3983
2015 Q1	$624K	Sell	87,354 -679	-0.8%	-$4.68K	﹤0.01%	3464
2014 Q4	$656K	Sell	88,033 -17,819	-17%	-$151K	﹤0.01%	3449
2014 Q3	$979K	Buy	105,852 +8,039	+8%	+$109K	﹤0.01%	3333
2014 Q2	$1.82M	Buy	97,813 +14,191	+17%	+$241K	﹤0.01%	3233
2014 Q1	$1.55M	Buy	+83,622	New	+$1.59M	﹤0.01%	3272

Other funds holding KIN

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

BlackRock Institutional Trust's KIN Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Kindred Biosciences, Inc. (KIN) stake by 0.81% in Q4 2016, selling an estimated $2.3K and leaving 58,390 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #3565.

BlackRock Institutional Trust first reported a position in KIN in Q1 2014 and has held it in 10 quarters since. The position peaked at $1.82M in Q2 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

BlackRock Institutional Trust held 58,390 shares of Kindred Biosciences, Inc. worth $248K as of Q4 2016.
BlackRock Institutional Trust sold 476 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $2.3K.
Kindred Biosciences, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3565 holding.
BlackRock Institutional Trust first reported a position in Kindred Biosciences, Inc. in Q1 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Kindred Biosciences, Inc. position peaked at $1.82M in Q2 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.